Introduction
Coil embolization of brain aneurysms is a well-established alternative to surgery in the treatment of ruptured, unruptured and asymptomatic aneurysms [1] [2] [3] [4] [5] [6] [7] . The progressive reduction of peri-procedural complications and the results of multicentric studies like ISAT and ISUIA have made endovascular intervention the first choice treatment in many hospitals [8] [9] [10] . When aneurysm morphology and location are appropriate the aneurysm can be completely excluded from the circulation by microcatheterization and coil embolization 11, 12 . However, fusiform aneurysms, giant lesions (maximum diameter > 10 mm) and wide-necked aneurysms [13] [14] [15] [16] remain a challenge. Wide-necked aneurysms have a maximum neck diameter > 4 mm or a dome/neck ratio < 2 17 entailing a high risk of coil migration during the embolization procedure. This complication increases the likelihood of thrombo-embolism until the artery supplying the aneurysm has been completely occluded.
In 1997 Moret et Al. first described the "remodelling" technique in the treatment of widenecked aneurysms 18 . The technique consists in placement of a balloon across the neck of the aneurysm and inflating it as a means of protection during the release of each coil [19] [20] [21] [22] [23] [24] . Another option is the use of three-dimensional coils serving as containers for subsequently deployed coils 25, 26 . Between 1997 and 1998 a number of authors described their first experiences
Summary
We positioned the following self-expanding stents certified for intracranial application: 16 Neuroform (Boston Scientific), three INX (Medtronic), one Leo (Balt). 6F calibre femoral introducers and guiding catheters were used for stent placement changing to 5F calibre introducers and guiding catheters (Envoy, Cordis) for the Neuroform 2 and 3 stents. All procedures were carried out under general anaesthesia and heparinization. Our pharmacological protocol consisted of adjunctive treatment with anti-aggregants during the interventional procedure and for the following six months, without premedication. From November 2000 to August 2006 we treated 28 patients (27 F/1M) with giant wide-necked aneurysms and one dissecting basilar artery aneurysm requiring the placement of 29 stents.
We successfully positioned 20 stents: 11 stents combined with coils (8 immediate; 3 late) with complete exclusion of the aneurysm from the circulation in seven cases and subtotal exclusion in four; nine stents not followed by embolization with complete exclusion of the aneurysm from the circulation in six cases and subtotal exclusion in three.
Stenting was not possible in nine cases due to extreme vessel tortuosity and the poor flexibility of release systems for the first stents. No late stent occlusion or subarachnoid haemorrhage were encountered after treatment.
20
of intracranial stent-assisted coil placement [27] [28] [29] [30] [31] [32] . The stent is positioned across the neck of the aneurysm to prevent coil migration through its mesh. In addition to ongoing improvements to this technique the embolizing agent Onyx was subsequently injected after stent placement. The use of one technique rather than another in different institutions is usually dictated by personal experience, preference and ease of handling. We opted for stenting combined when necessary with coil embolization. We report our experience and the reasons behind our choice of technique.
Material and Methods
All stents were certified for intracranial use. Neuroform stents (Boston Scientific) were positioned in 16 patients 33 , INX stents (Medtronic) in three and Leo stents (BALT) in one patient. INX stents were used from 2000 to 2001 in the initial period of stenting at our hospital. The Leo stent was used when maximum length was required.
We used 6F femoral introducers and guiding catheters changing to Envoy 5F-Cordis catheters with an internal diameter of 0.056 inch with Neuroform stents 2 and 3.
All procedures were carried out in the angiography suite in the Neuroradiology Unit of Bellaria Hospital using a monoplane angiogram (Philips) from 2000 to 2001 and a biplane device (General Electric) from 2002 to date.
All patients underwent endovascular treatment under general anaesthesia and the following medical management protocol. Before the procedure i.v. heparin was administered to obtain coagulation times between 250 and 350 s, and a 1000 mg bolus of lysine acetylsalicilyc acid (Aspegic). After the procedure and for the following 48 h, enoxaparin (Clexane) 4 x 2 was associated with ticlopidine (Tiklid) 250 x 2, acetyl salicylic acid (Ascriptin) 0.3 x 1, ranitidine (Zantac) one 150 mg tab daily. Anti-aggregant therapy was administered at these doses for seven days after the procedure. Ticlopidine (Tiklid) was subsequently reduced to 250 x 1 and continued alongside the other drugs at the same doses for seven days. Ticlopidine (Tiklid) was then suspended and acetyl salicylic acid (Ascriptin) 0.3 x 1, ranitidine (Zantac) one 150 mg tab daily continued for six months. No premedication was given prior to Neuroform stent insertion.
Haemochrome was measured on the tenth day of treatment to disclose possible low platelet levels. In Italy clopidogrel bisulfate (Plavix) is not given to patients without cardiopathy. When possible clopidogrel bisulfate (Plavix) can replace ticlopidine (Tiklid) at a dose of 75 mg daily.
From November 2000 to April 2006 28 patients (27F/1M) with wide-necked aneurysms, including one dissecting basilar artery aneurysm, were referred to our Unit. Twelve of these patients had multiple aneurysms. Placement of Right stent placement failed in this case due to extreme vessel tortuosity.
Results
Twenty stents were positioned successfully (see Tables A and B ). The following treatment strategies were adopted:
Immediate post-stent embolization in eight patients with complete exclusion of the aneur- ysm from the circulation in four and subtotal exclusion in four. One giant aneurysm presented subtotal exclusion from the circulation after coil embolization so that embolization was completed after Neuroform stent placement.
Late post-stent embolization in three patients with complete exclusion of the aneurysm from the circulation;
Stent placement without embolization in nine patients with complete exclusion from the circulation of five aneurysms and one dissecting pseudo-aneurysm. These lesions had already been treated by embolization in two cases and surgery in one, all of which revascularized.
The following disease-related complications were encountered in our series: -Vasospasm (3 cases); The following tehnique-related complications were encountered in our series: -Coil migration through the stent's mesh (1 case); -Acute thrombosis within the stent successfully treated with urokinase (1 case); Stent migration into the aneurysm during deployment of the microcatheter with coils (1 case) ( figure 3C) ; Stent detachment from the release system and distal arterial migration in the left popliteal artery (1 case).
In patients with technique-related complications, the outcomes were good, without clinical consequence.
Nine stents could not be positioned due to extreme vessel tortuosity and the limited flexibility of early stent release systems. The following treatment strategies were adopted: -3D coil embolization (Micrus endovascular) in three patients with subtotal exclusion; -Surgery in six patients.
Long-term follow-up monitoring was done with: -MR angiography if coils were present in the aneurysmal sac, -CT angiography if only the stent was present, -Angiography if aneurysm revascularization was suspected. Follow-up has lasted more than 24 months in six patients. We are not aware of any cases of late stent occlusion or SAH after treatment.
Discussion
The most important factors in the choice of aneurysm management are efficacy and patient safety. When the aneurysm is amenable, patient safety is ensured by the simplest, shortest and least invasive procedure.
The remodelling technique carries several disadvantages including possible balloon-induced injury to the arterial wall or vasospasm, longer execution times due to recurrent intermittent vessel occlusion, the risk of delayed coil migration, and the concomitant use of two catheters, one for coils, the other for the balloon, with double femoral access or a single large diameter access (at least 7F). Luzardo et al. recently described improved single access in 48 patients using a new 6F guiding catheter with an internal diameter of 0.070 inch (Envoy 6F, Cordis) 35 . Despite this, the technique appears cumbersome, especially considering the reported outcomes: literature reports give rates of aneurysm exclusion from the circulation varying from 67 to 83%, with technical failure rates of around 23% 36 .
Three-dimensional coil embolization is a reliable method. Leonardi treat wide-necked aneurysms 37 . The procedure was effective for lesions with a dome/ neck ratio of 1.5, but unreliable for the embolization of very wide-necked aneurysms. In patients 10, 11, 12, 13, 14 in our series, the first choice treatment was 3D coil embolization: results were unsatisfactory and intracranial stents were subsequently positioned in these cases. Stenting became a more attractive technique after the introduction of self-expanding stents devised for intracranial deployment. Before this balloon-expanded coronary stents not certified for intracranial insertion had been used. These stents had limited flexibility and navigability in the intracranial arteries, especially the distal stretches, whereas the new self-expanding stents have a narrower release system calibre offering greater flexibility and arterial naviga- bility, and reducing arterial wall injury. In addition to preventing coil migration, stents also have therapeutic advantages. The stent mesh aids endothelial growth, favouring coil compaction and reducing blood inflow into the aneurysm, thereby leading to stasis and hence thrombosis as demonstrated in experimental and clinical studies [38] [39] [40] [41] [42] [43] . All these factors led to the development of the overlapping technique, i.e. overlapping two stents across the aneurysm neck to reduce the amplitude of the stent mesh, thereby enhancing the therapeutic properties of the stent 44, 45 . On the other hand, the overlap of two stents and the resulting reduction in vascular lumen also increases the likelihood of thrombus formation within the stent. This drawback and the greater technical complexity of the procedure led us to prefer single stent placement across the aneurysm neck for the following reasons:
Stability over time. A wire mesh is positioned across the aneurysm neck.
Relatively simple procedure. Possibility of dividing up the procedure in difficult cases. The stent is positioned during the first treatment session to reduced inflow into the aneurysm. Coil embolization is performed at a later date. An interventional procedure should not last too long as the longer catheters remain in the vasculature, the greater the risk of complications even when the patient is under total heparinization.
Occlusion of the aneurysm with the placement of a single stent.
After stent placement in patients presenting marked stasis of contrast medium we opted not to proceed to coil embolization, especially in small aneurysms with a greater risk of perforation. Aware of the correlation between aneurysm growth and rupture and internal flow within the lesion, stent characteristics are extremely important to curb inflow 46 .
We have used only certified material devised for intracranial use both for patient safety and for legal reasons. Boston Scientific Neuroform stents were positioned in the majority of our patients. This is a self-expanding nitinol stent with a 3F maximum calibre over-the-wire release system. The stent is divided into segments joined in two places making it more flexible and adaptable to the vascular curvature and distal arterial navigation. The device has an open cell design characterized by mesh widening along the external margin of sharp arterial bends, reducing the risk of occluding arterial collaterals and particularly suited to the treatment of aneurysms in the T bifurcations. Its low radial force cannot dilate arteries with a calibre narrower than that of the stent [47] [48] [49] , and it also has low thrombogenicity 50 . The enhanced flexibility of the Neuroform 2 51 and especially the more recent Neuroform 3 stents allows them to be deployed using smaller calibre guiding catheters. This has facilitated intracranial arterial navigation reducing the risk of vessel wall injury and occlusion, namely in the vertebral arteries. It was thus possible to use 5F calibre femoral introducers, thereby facilitating arterial compression at the end of the procedure.
Coils were the only embolizing material injected in our series. Despite many literature reports, we did not use Onyx for the following reasons: -it requires balloon assistance with the risk of arterial wall injury; -two concomitant microcatherters are required, one for the balloon the other for the Onyx, entailing double femoral access; -the procedure itself lasts longer and is further prolonged by repeated arterial occlusions.
The decision not to administer anti-aggregant pre-medication prior to Neuroform stent insertion was based on the fact that correct stent placement could not be guaranteed and patients with ruptured or unruptured aneurysms would in any case be exposed to the risks of anti-aggregant drugs. By contrast, adjunctive treatment with anti-aggregants during the interventional procedure and for the following six months is essential. This protocol yielded excellent results without complications even treating acute cases, namely the dissecting pseudo-aneurysm of the basilar artery 52 and more recently the giant aneurysm of the basilar artery apex associated with massive subarachnoid haemorrhage refractory to surgical management. Excellent outcomes have also been reported by Katsaridis et al. using a similar therapeutic protocol 53 .
Conclusions
Self-expanding stents are a reliable means of treating wide-necked intracranial aneurysms. The devices can be adapted to the individual patient's needs, and are relatively simple to position given the complexity of these lesions.
